Speaker illustration

Doctor Francesca Stillitano

Icahn School of Medicine at Mount Sinai, New York (United States of America)

Gene therapy to avoid development of cardiomyopathy

Event: ESC Preventive Cardiology 2023

Topic: Biomarkers

Session: How genes and the environment interact to shape individual CV risk


Genetic correction of phospholamban mutations in vitro and in vivo human-based models

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Genetics, Epigenetics, ncRNA

Session: Gene editing for the heart: progress and hurdles


In vitro and in vivo genome engineering of Dilated Cardiomyopathy caused by phospholamban R14 deletion.

Event: Frontiers in CardioVascular Biology 2016

Topic: Gene therapy

Session: Moderated Poster session - Genetic, Epigenetic & Integrative


Modeling susceptibility to drug-induced long qt syndrome with a panel of subject-specific induced pluripotent stem cells

Event: Frontiers in CardioVascular Biology 2016

Topic: Cell growth, differentiation and stem cells - Heart

Session: Control of rhythm and rate


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb